Immunomodulation with interferon‐gamma and colony‐stimulating factors for refractory fungal infections in patients with leukemia
Abstract
BACKGROUND: Invasive fungal infections (IFI) in immunocompromised patients are associated with significant morbidity and mortality, despite appropriate antifungal treatment and recovery from neutropenia. The outcome of these infections depends significantly on the overall state of immunosuppression, including mainly the phagocytic system (neutrophils and macrophages). Interferon‐gamma (IFN‐γ), granulocyte‐colony—stimulating factor (G‐CSF) and granulocyte‐macrophage—colony‐stimulating factor (GM‐CSF) are cytokines that enhance the activity of neutrophils and macrophages.METHODS: The authors reported 4 patients with leukemia and refractory invasive candidiasis or trichosporonosis despite 1–13 months of appropriate antifungal treatment.RESULTS: Cytokines were administered for 1.5–5 months without significant toxicity. For each patient, initiation of interferon‐gamma plus a colony‐stimulating factor resulted in a clinical response. The contribution of cytokines to control the fungal infection in these 4 patients was suggested by the strong inflammatory reaction observed in the 2 patients who had an immediate response (within 7 days of initiation of cytokine therapy) and by the good outcome in the 2 other patients in whom antifungal agents were discontinued at the start of cytokine therapy.CONCLUSIONS: These data suggested a potential role for immunomodulation in patients with leukemia with refractory invasive fungal infections. Cancer 2005. Published 2005 by the American Cancer Society.Keywords
This publication has 14 references indexed in Scilit:
- Successful Treatment of a Critically Ill Patient with Disseminated Coccidioidomycosis, Using Adjunctive Interferon‐γClinical Infectious Diseases, 2004
- Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignanciesBlood, 2002
- The Use of Adjuvant Interferon-γ Therapy for Hepatosplenic Blastoschizomyces capitatus Infection in a Patient with LeukemiaClinical Infectious Diseases, 2000
- Monocyte deactivation and its reversal in a patient with chemotherapy-induced leukopenia and severe systemic infectionMedical and Pediatric Oncology, 1999
- The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?Clinical Infectious Diseases, 1998
- ASPERGILLUS OSTEOMYELITIS IN CHRONIC GRANULOMATOUS DISEASE: TREATMENT WITH RECOMBINANT GAMMA-INTERFERON AND ITRACONAZOLEThe Pediatric Infectious Disease Journal, 1996
- Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemiaAnnals of Hematology, 1996
- Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous diseaseThe Pediatric Infectious Disease Journal, 1991
- Recombinant Human Interferon- as Adjunct Therapy for Aspergillus Infection in a Patient with Chronic Granulomatous DiseaseThe Journal of Infectious Diseases, 1991
- In Vivo Interferon- Therapy Augments the In Vitro Ability of Chronic Granulomatous Disease Neutrophils to Damage Aspergillus HyphaeThe Journal of Infectious Diseases, 1991